← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

#	Name	Funds holding	Growth	Growth %	Fund value
1	1 Pfizer PFE $166B	1,880	-8	-0.4%	$139B
2	2 Amgen AMGN $230B	1,382	+15	+1%	$84.4B
3	3 Eli Lilly LLY $1.08T	1,148	+9	+0.8%	$70.5B
4	4 Becton Dickinson BDX $51.5B	931	+14	+2%	$23.8B
5	5 McKesson MCK $114B	926	-28	-3%	$36.5B
6	6 Teva Pharmaceutical Industries Limited TEVA $47.5B	824	+5	+0.6%	$30B
7	7 Conagra Brands CAG $6.61B	638	-19	-3%	$13.6B
8	8 Regeneron Pharmaceuticals REGN $80.1B	563	+22	+4%	$34.1B
9	9 Novo Nordisk NVO $168B	526	+9	+2%	$11B
10	10 DaVita DVA $11.5B	471	-26	-5%	$13B
11	11 AstraZeneca AZN $251B	371	-5	-1%	$6.54B
12	12 ResMed RMD $33.1B	314	+1	+0.3%	$3.93B
13	13 Opko Health OPK $1.02B	268	+49	+22%	$1.04B
14	14 Accendra Health ACH $24.1M	251	+12	+5%	$2.09B
15	15 West Pharmaceutical WST $26.4B	248	+29	+13%	$3.66B
16	16 Herbalife HLF $1.49B	211	-1	-0.5%	$5.29B
17	17 Dr. Reddy's Laboratories RDY $10.6B	206	+16	+8%	$1.79B
18	18 MannKind Corp MNKD $971M	185	-3	-2%	$354M
19	19 DELISTED CATALENT, INC. CTLT	176	+27	+18%	$3.04B
20	20 Tootsie Roll Industries TR $2.87B	167	+4	+2%	$422M
21	21 Fresenius Medical Care FMS $11.5B	141	-3	-2%	$450M
22	22 Alaunos Therapeutics TCRT $5.26M	138	-18	-12%	$570M
23	23 Medifast MED $132M	125	-4	-3%	$255M
24	ARNA 24 DELISTED Arena Pharmaceuticals Inc ARNA	120	-10	-8%	$268M
25	25 DELISTED WW International WW	115	0	0%	$352M